Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1) and can be used to synthesize the antibody-drug conjugate Lorvotuzumab mertansine.
Purity:
>95%
CAS Number:
[339306-30-8]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted